OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
QMDT59

Q & M Dental Group (Singapore) Ltd

Healthcare Facilities & ServicesVerified

Q & M Dental Group (Singapore) Ltd maintains a liquidity position with a current ratio of 4.75, indicating strong short-term liquidity. However, the company's debt-to-equity ratio of 1.81 suggests a relatively high level of leverage, which could pose a risk to financial stability. The company's cash and equivalents amount to SGD 117.085 million, but this is offset by long-term debt of SGD 188.495 million, resulting in a net cash position that is negative after subtracting total debt. In terms of profitability, the company's return on equity (ROE) is 8.92%, which is a strong return relative to its equity base. However, its return on assets (ROA) is 2.64%, which is relatively modest and may indicate that the company is not efficiently utilizing its assets to generate returns. The operating margin, calculated as operating income of SGD 18.729 million on revenue of SGD 197.226 million, is 9.49%, which is in line with industry norms for dental service providers. The company's revenue is concentrated in Singapore, as disclosed in its financial statements, with no material geographic diversification reported. The business operates primarily through its dental clinics, and there are no disclosed segments beyond this core activity. This lack of diversification could expose the company to regional economic or regulatory risks. Looking ahead, the company's revenue is expected to grow, with analysts providing a mean price target of SGD 0.62 and a median price target of SGD 0.64. The mean recommendation of 2.00 suggests a generally positive outlook, with one strong-buy, one buy, and one hold recommendation. The company's capital expenditure of SGD -4.972 million indicates a reduction in investment in physical assets, which may reflect a shift in strategic focus or a response to market conditions. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key risk flag is the negative net cash position after subtracting total debt, which could limit the company's ability to fund operations or pursue growth opportunities without external financing. No recent significant events, such as major filings or transcripts, have been disclosed that would materially affect the company's operations or financial position.

30-day price · QMDT+0.01 (+0.8%)
Low$0.57High$0.61Close$0.59As of22 May, 00:00 UTC
Profile
CompanyQ & M Dental Group (Singapore) Ltd
TickerQMDT.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Q & M Dental Group (Singapore) Ltd provides dental care services and operates dental clinics in Singapore, generating revenue primarily through patient consultations and dental procedures.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Q & M Dental Group (Singapore) Ltd maintains a liquidity position with a current ratio of 4.75, indicating strong short-term liquidity. However, the company's debt-to-equity ratio of 1.81 suggests a relatively high level of leverage, which could pose a risk to financial stability. The company's cash and equivalents amount to SGD 117.085 million, but this is offset by long-term debt of SGD 188.495 million, resulting in a net cash position that is negative after subtracting total debt. In terms of profitability, the company's return on equity (ROE) is 8.92%, which is a strong return relative to its equity base. However, its return on assets (ROA) is 2.64%, which is relatively modest and may indicate that the company is not efficiently utilizing its assets to generate returns. The operating margin, calculated as operating income of SGD 18.729 million on revenue of SGD 197.226 million, is 9.49%, which is in line with industry norms for dental service providers. The company's revenue is concentrated in Singapore, as disclosed in its financial statements, with no material geographic diversification reported. The business operates primarily through its dental clinics, and there are no disclosed segments beyond this core activity. This lack of diversification could expose the company to regional economic or regulatory risks. Looking ahead, the company's revenue is expected to grow, with analysts providing a mean price target of SGD 0.62 and a median price target of SGD 0.64. The mean recommendation of 2.00 suggests a generally positive outlook, with one strong-buy, one buy, and one hold recommendation. The company's capital expenditure of SGD -4.972 million indicates a reduction in investment in physical assets, which may reflect a shift in strategic focus or a response to market conditions. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The key risk flag is the negative net cash position after subtracting total debt, which could limit the company's ability to fund operations or pursue growth opportunities without external financing. No recent significant events, such as major filings or transcripts, have been disclosed that would materially affect the company's operations or financial position.
Key takeaways
  • Q & M Dental Group (Singapore) Ltd has a strong current ratio of 4.75, indicating robust short-term liquidity.
  • The company's debt-to-equity ratio of 1.81 suggests a high level of leverage, which could pose a risk to financial stability.
  • The company's ROE of 8.92% is strong, but its ROA of 2.64% is relatively modest.
  • The company's revenue is concentrated in Singapore, with no material geographic diversification reported.
  • Analysts have a generally positive outlook, with a mean price target of SGD 0.62 and a median price target of SGD 0.64.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue$197.2M
Gross profit$171.6M
Operating income$18.7M
Net income$9.3M
R&D
SG&A
D&A
SBC
Operating cash flow$36.9M
CapEx-$5.0M
Free cash flow$14.2M
Total assets$352.4M
Total liabilities$248.0M
Total equity$104.4M
Cash & equivalents$117.1M
Long-term debt$188.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$104.4M
Net cash-$71.4M
Current ratio4.8
Debt/Equity1.8
ROA2.6%
ROE8.9%
Cash conversion4.0%
CapEx/Revenue-2.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
MetricQMDTActivity
Op margin9.5%5.6% medp25 -4.2% · p75 12.6%above median
Net margin4.7%2.8% medp25 -3.4% · p75 8.8%above median
Gross margin87.0%36.5% medp25 23.7% · p75 65.2%top quartile
CapEx / revenue-2.5%-4.9% medp25 -11.5% · p75 -2.0%above median
Debt / equity181.0%69.3% medp25 7.9% · p75 120.9%top quartile
Observations
IR observations
Mean price target0.62 SGD
Median price target0.64 SGD
High price target0.68 SGD
Low price target0.55 SGD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.01 SGD
Last actual EPS0.01 SGD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-23 12:15 UTC#7913cb58
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 03:07 UTCJob: 87decb53